Acer Therapeutics down 33% despite winning FDA approval for urea cycle disorders treatment

Dec. 27, 2022 2:24 PM ETRelief Therapeutics Holding AG (RLFTF), RLFTY, ACERBy: Jonathan Block, SA News Editor

Red arrow And dollar finance decline graph- Stock image


Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.